loadpatents
Patent applications and USPTO patent grants for Mandhare; Appaji Baburao.The latest application filed is for "novel dual action receptors antagonists (dara) at the ati and eta receptors".
Patent | Date |
---|---|
Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes Grant 7,750,020 - Bebernitz , et al. July 6, 2 | 2010-07-06 |
Novel Dual Action Receptors Antagonists (Dara) at the Ati and Eta Receptors App 20100010035 - Gupta; Ramesh Chandra ;   et al. | 2010-01-14 |
Sulfonamide-Thiazolpyridine Derivatives As Glucokinase Activators Useful The Treatment Of Type 2 Diabetes App 20080103167 - Bebernitz; Gregory Raymond ;   et al. | 2008-05-01 |
Thiazolopyridine Derivatives, Pharmaceut Ical Conditions Containing Them And Methods Of Treating Glucokinase Mediated Conditions App 20070265297 - Bebernitz; Gregory Raymond ;   et al. | 2007-11-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.